Intraabdominal Infections: Clinical Trials

39 trials for Intraabdominal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 4 unknown, 2 not yet recruiting, 2 terminated. 39 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 339Completed 30, Unknown 4, Not yet recruiting 2, Terminated 2, Recruiting 1
Phase 25Completed 4, Unknown 1

Follow Intraabdominal Infections: new trials by email Literature Review of Intraabdominal Infections trials Research Report on Intraabdominal Infections

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic
Phase 3Not yet recruitingMcMaster Children's Hospital1802027-04-012026-10-09
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
Meropenem and Pralurbactam, Saline, Ceftazidime-avibactam - Intra-abdominal Infections
Phase 3Not yet recruitingQilu Pharmaceutical Co., Ltd.7862024-10-312024-10-09
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
Ketorolac Tromethamine, Morphine Sulfate, normal saline - Acute Pain, Abdomen, Acute
Phase 3RecruitingUniversity of Calgary4952024-05-272024-06-24
Comparison of Ketorolac at Three Doses in Children With Acute Pain
Ketorolac Tromethamine - Acute Pain, Abdominal Pain
Phase 3CompletedHamilton Health Sciences Corporation1712023-06-012025-07-09
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD)
Phase 2 / Phase 3CompletedKarl Landsteiner Insitute for Nephrology and Haemato-Oncology122021-08-312025-08-11
Ketorolac for Moderate to Severe Abdominal Pain in Children
Ketorolac Tromethamine 10 MG/ML, Morphine Sulfate 10Mg/1mL Injection - Abdominal Pain, Appendicitis
Phase 3CompletedHamilton Health Sciences Corporation1052021-05-052023-02-28
Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
Ertapenem, Sulopenem-Etzadroxil/Probenecid, Ciprofloxacin - Intra Abdominal Infections
Phase 3CompletedIterum Therapeutics, International Limited6742018-09-182020-12-01
Non-operative Treatment of Acute Non-perforated Appendicitis
Meronem and flagyl, Appendectomy - Acute Appendicitis
Phase 2 / Phase 3CompletedKing Edward Medical University1802018-09-012021-02-18
Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites
Rifaximin, Placebo - Cirrhosis, Ascites
Phase 3CompletedCentre Hospitalier Universitaire de Besancon1602018-06-052025-04-10
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Reltecimod 0.5 mg/kg, Placebo - Acute Kidney Injury, Peritonitis
Phase 3TerminatedAtox Bio Ltd582018-05-242021-10-12
Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique
Abthera, Barker - Abdominal Trauma, Abdominal Sepsis
Phase 3UnknownSociedade Brasileira de Atendimento Integrado ao Trauma942017-07-012017-04-25
Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)
MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g), metronidazole 500 mg - Intra-abdominal Infection, Complicated Intra-abdominal Infection
Phase 3CompletedMerck Sharp & Dohme LLC1002016-04-082018-08-09
The Onset Time of Rocuronium in Emergency and Elective Surgery
Rocuronium elective surgery, Rocuronium emergency surgery, Propofol - Inguinal Hernia, Acute Appendicitis
Phase 3UnknownDiskapi Yildirim Beyazit Education and Research Hospital502015-12-012015-12-18
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Vabomere, Best Available Therapy - Urinary Tract Infection Complicated, Acute Pyelonephritis
Phase 3CompletedRempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)772014-07-012019-03-04
Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
glycopeptide plus carbapenem, Haizheng Li Xing ® plus tazocin ® - Abdominal Infection
Phase 2 / Phase 3UnknownTianjin Medical University Cancer Institute and Hospital1002014-05-012014-07-16
Antibiotic Safety (SCAMP)
ampicillin and metronidazole and gentamicin, ampicillin and gentamicin and clindamycin, gentamicin and Piperacillin- tazobactam - Complicated Intra Abdominal Infections
Phase 2 / Phase 3CompletedMichael Cohen-Wolkowiez2602013-12-012019-05-30
Feasibility of Outpatient Appendectomy for Acute Appendicitis
outpatient surgery - Acute Appendicitis
Phase 3CompletedCentre Hospitalier Universitaire, Amiens1202013-04-012025-09-22
Laparoscopic Appendectomy by Multi-port vs Single Port.
Single incision laparoscopic appendectomy, Multiport laparoscopic appendectomy - Acute Appendicitis
Phase 3UnknownAssociazione Chirurghi Ospedalieri Italiani3002013-03-012012-11-05
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
Metronidazole, Ceftriaxone sodium - Intra-abdominal Infections
Phase 3CompletedPfizer382011-11-012014-01-24
Duration of Antibiotic Therapy in the Treatment of Severe Postoperative Peritonitis Admitted in ICU
Duration of antibiotic therapy limited to 8 days - Postoperative Peritonitis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2442011-05-012015-12-09

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Appendicitis (17)  ·  Peritonitis (10)  ·  Abdominal Pain (5)  ·  Abdomen, Acute (2)  ·  Abdominal Abscess (2)  ·  Acute Pain (2)  ·  Bacterial Infections and Mycoses (2)  ·  Cholecystitis (2)  ·  Cross Infection (2)  ·  Emergencies (2)  ·  Pancreatitis (2)  ·  Sepsis (2)  ·  Abdominal Injuries (1)  ·  Acute Kidney Injury (1)

Broader conditions

Infections (38)  ·  Digestive System Diseases (26)  ·  Cecal Diseases (17)  ·  Gastroenteritis (17)  ·  Gastrointestinal Diseases (17)  ·  Intestinal Diseases (17)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (12)  ·  Peritoneal Diseases (11)  ·  Disease Attributes (6)  ·  Neurologic Manifestations (6)  ·  Signs and Symptoms (6)  ·  Pain (5)  ·  Signs and Symptoms, Digestive (5)

Interventions

Metronidazole (9)  ·  Meropenem (4)  ·  Amoxicillin-Potassium Clavulanate Combination (3)  ·  Ceftriaxone (3)  ·  Doripenem (3)  ·  Ertapenem (3)  ·  Ketorolac Tromethamine (3)  ·  Moxifloxacin (3)  ·  Piperacillin, Tazobactam Drug Combination (3)  ·  Saline Solution (3)  ·  Amoxicillin (2)  ·  Morphine (2)  ·  Sodium Chloride (2)  ·  AB103 (1)  ·  Acetylcysteine (1)

Sponsors

Bayer (2)  ·  Hamilton Health Sciences Corporation (2)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Merck Sharp & Dohme LLC (2)  ·  All India Institute of Medical Sciences (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Associazione Chirurghi Ospedalieri Italiani (1)  ·  Atox Bio Ltd (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Chinese University of Hong Kong (1)  ·  Diskapi Yildirim Beyazit Education and Research Hospital (1)  ·  Heidelberg University (1)  ·  Hospital Universitario Virgen de la Arrixaca (1)  ·  Iterum Therapeutics, International Limited (1)

Countries

United States (8)  ·  Canada (6)  ·  China (5)  ·  France (5)  ·  Argentina (3)  ·  Latvia (3)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Chile (2)  ·  Colombia (2)  ·  Czechia (2)  ·  Germany (2)  ·  Greece (2)  ·  Hungary (2)  ·  Italy (2)

Top investigators

Mohamed Eltorki, MBChB (2)  ·  Alexandra Heurgue-Berlot, MD (1)  ·  Alexandre Louvet, MD, PhD (1)  ·  Anthony Y Teoh, FRCSEd (Gen) (1)  ·  Azra Bihorac, MD (1)  ·  Barbara Culbreath, RN (1)  ·  Christophe Bureau, MD, PhD (1)  ·  Claire Francoz, MD (1)  ·  Didier Payen, MD (1)  ·  Dr Govind K Makharia, MD, DM, DNB (1)  ·  Edouard Bardou-Jacquet, MD (1)  ·  Eric Nguyen-Khac, MD, PhD (1)

Results publications

PMID 19670912, PMID 20211892, PMID 17359318, PMID 17916243, PMID 19036670, PMID 20663130, PMID 21339413, PMID 22533576, PMID 23154391, PMID 23386239, PMID 23616495, PMID 23772043, PMID 24022431, PMID 25073872, PMID 25442806, PMID 25862039, PMID 25969531, PMID 25992746, PMID 27437029, PMID 29356761, PMID 29484469, PMID 30270406, PMID 30528561, PMID 31096041, PMID 33565042, PMID 33902072, PMID 35383071, PMID 40653111, PMID 40913503, PMID 41066173

NIH funding

2009 (2), R01GM081510 (1)